The 2022 CIMT Annual Meeting will take place May 10-12, 2022. More information will be provided as it becomes available.
Read MoreOn June 2, CIMT members gathered online for the 2021 CIMT general assembly and re-elected board members Prof. Carl Figdor and Prof. Kees Melief.
Read MoreSix early-career researchers have been chosen by the CIMT Annual Meeting poster jury to receive the 2019 CIMT Poster Awards. One eTalk winner was selected by the meeting audience.:
We congratulate Alejandro Hernandez-Sanchez (German Cancer Research Center), Paola Bonaventura (Cancer Research Center of Lyon), Leonie Rosenberger (Charité-Universitätsmedizin ), Miro Raeber (University Hospital Zurich), Marie Christine Viuff (Technical University of Denmark), Francesca Simoncello (International Centre for Genetic Engineering and Biotechnology)
Because of the ongoing meeting restrictions, the 2021 CIMT Members General Meeting will take place on June 2, 20:00-21:00 (CEST), in a virtual format. CIMT members will receive their login information via email.
Read MoreThe virtual 18th Annual Meeting of the Association for Cancer Immunotherapy CIMT was opened today by CIMT President Özlem Türeci with over 800 cademic and clinical professionals in the fields of tumor immunology attending online. Over 220 submitted abstracts are presented online as eTalks.
Read MoreAll abstracts and the day-to-day 2021 Annual Meeting program can be accessed at www.meeting.cimt.eu/program.
Read More
The Italian immunologist Alberto Mantovani will be honored by CIMT for life-time achievements in cancer immunotherapy research. The prize will be awarded on the evening of Monday, May 10 at 7 p.m., as part of the virtual Annual Meeting of the Association for Cancer Immunotherapy CIMT, May 10-12, 2021.
Read MoreThe Association for Cancer Immunotherapy remembers the life and pioneering work of Giorgio Parmiani, MD, who was internationally recognized in the field of tumor immunology and immunotherapy.
Read MoreWe congratulate CIMT President Özlem Türeci who together with Ugur Sahin will receive the Knight Commander's Cross of the Federal Order of Merit (Bundesverdienstkreuz) for developing a coronavirus vaccine.
Read More